48,460
edits
m (→IHC) |
m (→IHC) |
||
Line 745: | Line 745: | ||
*SMAD4 -ve ~55% of cases -- stomach usually +ve. | *SMAD4 -ve ~55% of cases -- stomach usually +ve. | ||
*CDX2 -ve/+ve. | *CDX2 -ve/+ve. | ||
*CEA +ve.<ref name=pmid16183479>{{Cite journal | last1 = Adsay | first1 = NV. | last2 = Basturk | first2 = O. | last3 = Cheng | first3 = JD. | last4 = Andea | first4 = AA. | title = Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. | journal = Semin Radiat Oncol | volume = 15 | issue = 4 | pages = 254-64 | month = Oct | year = 2005 | doi = 10.1016/j.semradonc.2005.04.001 | PMID = 16183479 }}</ref> | |||
==Pancreatic neuroendocrine tumour== | ==Pancreatic neuroendocrine tumour== |
edits